Susan Kuo is a postdoctoral fellow in Elise Robinson’s lab at the Broad Institute of MIT and Harvard in Cambridge, Massachusetts.
Susan Kuo
Postdoctoral fellow
Broad Institute of MIT and Harvard
From this contributor
What developmental milestones say about autism research: A conversation with Susan Kuo and Elise Robinson
Shifts in diagnostic criteria have only added to the condition’s bedeviling heterogeneity, an analysis of smiling, sitting, walking and other early milestones in more than 17,000 autistic children reveals.
What developmental milestones say about autism research: A conversation with Susan Kuo and Elise Robinson
By
Sarah DeWeerdt
10 August 2022 | 7 min read
Explore more from The Transmitter
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
How to teach programming in the age of AI
Scientists and educators are concerned about students using artificial intelligence to shortcut their learning. But there are also opportunities, especially when it comes to teaching neuroscience students how to code.
By
Ashley Juavinett
30 March 2026 | 8 min read
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
Neuroscience conference policy draws confusion, apology
NeurIPS organizers apologized and altered course after issuing a policy that barred submissions from researchers at U.S.-government-sanctioned institutions.
By
Dalmeet Singh Chawla
27 March 2026 | 5 min read
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
Funding for animal research alternatives reaches ‘inflection point’
The United States and Europe are dedicating hundreds of millions of dollars in funding to advance novel alternative methods, but not all neuroscientists see this as a positive step.
By
Claudia López Lloreda
26 March 2026 | 4 min read